Review: Antileukotrienes are less effective than inhaled corticosteroids in chronic asthma
- Comparing leukotriene inhibitors and corticosteroids in asthma. Pinkowish, Mary Desmond // Patient Care;6/15/1999, Vol. 33 Issue 11, p34
Compares the efficacy of inhaled corticosteroids and oral leukotriene receptor antagonists as treatments for asthma. Positive and negative aspects of the treatments; Oral agents as easier for patients to use; Understanding of the pathophysiology of asthma; Patients' preference for taking pills...
- Cost-Efficacy Analysis of Fluticasone Propionate versus Zafirlukast in Patients with Persistent Asthma. Menendez, R.; Stanford, R.H.; Edwards, L.; Kalberg, C.; Rickard, K. // PharmacoEconomics;Aug2001, Vol. 19, p865
Objective: To compare the relative value of an inhaled corticosteroid, fluticasone propionate 88Âµg twice daily, versus an oral leukotriene receptor antagonist, zafirlukast 20mg twice daily, in patients with persistent asthma currently receiving short acting Î²-agonists alone. Study design:...
- Don't wait to inhale. Lee, Janet // Self;Apr2000, Vol. 22 Issue 4, p84
Presents treatments for asthma. Corticosteroids, for severe asthma; Anti-leukotrienes, for moderate asthma; Natural remedies for the disease.
- LOCSS trial: Once-daily fluticasone plus salmeterol superior to montelukast as step-down therapy for mild persistent asthma. // Formulary;Aug2007, Vol. 42 Issue 8, p490
The article focuses on the therapeutic use of fluticasone plus salmeterol for mild persistent asthma. The Leukotriene of Corticosteroid or Corticosteroid-Salmeterol (LOCSS) trial demonstrated that in patients whose asthma was well controlled using fluticasone twice daily, switching to...
- Leukotriene Antagonists Offer a New Mechanism for Asthma Control. Capriotti, Teri // MEDSURG Nursing;Oct99, Vol. 8 Issue 5, p318
Examines the effectiveness of leukotriene antagonists as an anti-inflammatory medication for asthma. Description of leukotrienes; Forms of corticosteroid control of inflammation; Indications for leukotriene antagonists; Implications of leukotriene antagonists.
- Leukotriene Inhibitors in the Treatment of Allergy and Asthma. SCOW, DEAN THOMAS; LUTTERMOSER, GARY K.; DICKERSON, KEITH SCOTT // American Family Physician;2015 Special Issue, Vol. 91, p1
Leukotriene inhibitors are the first new class of medications for the treatment of persistent asthma that have been approved by the U.S. Food and Drug Administration in more than two decades. They also have been approved for the treatment of allergic rhinitis. Prescriptions of leukotriene...
- Treatment of Mild Persistent Asthma. Israel, Elliot // New England Journal of Medicine;5/17/2007, Vol. 356 Issue 20, p2096
The article presents the second treatment option for the online Clinical Decisions Forum on the treatment of a women with mild persistent asthma. The forum allows readers to decide which treatment they think is most appropriate and why. This article focuses on oral leukotriene-receptor...
- Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). Shrewsbury, Stephen; Pyke, Stephen; Britton, Mark // BMJ: British Medical Journal (International Edition);05/20/2000, Vol. 320 Issue 7246, p1368
Features a study which aimed to examine the benefits of adding salmeterol compared with increasing dose of inhaled corticosteroids in symptomatic asthma. Methodology of the study; Results and discussion; Conclusions.
- A Review of the Role of Inhaled Corticosteroids in the Treatment of Acute Asthma. Chipps, Bradley E.; Chipps, Donna R. // Clinical Pediatrics;Apr2001, Vol. 40 Issue 4, p185
Summary: Systemic corticosteroids (CSs) are generally accepted as treatment for acute exacerbations of asthma. In contrast, inhaled corticosteroids (ICs) have been used for the long-term management of asthma but are not widely accepted for the treatment of asthma exacerbations. The onset of...